Retinoid signaling alterations in amyotrophic lateral sclerosis

American Journal of Neurodegenerative Diseases

Volumn 1, Issue 2, 2012, Pages 130-145

  Kolarcik, Christi L ^a   Bowser, Robert ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Motor neuron; Motor neurons; Nuclear receptor; Oxidative stress induced cell death; Retinoic acid receptors; Retinoid signaling

Indexed keywords

RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR BETA; RETINOID;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; MALE; MIDDLE AGED; MOTONEURON; POLYMERASE CHAIN REACTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPINAL CORD; TUNEL ASSAY; VERY ELDERLY;

EID: 84980053733     PISSN: None     EISSN: 2165591X     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Andersen PM and Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 2011; 7: 603-615.
2. Cudkowicz M, Qureshi M and Shefner J. Measures and markers in amyotrophic lateral sclerosis. NeuroRx 2004; 1: 273-283.
3. Wichterle H, Lieberam I, Porter JA and Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002; 110: 385- 397.
4. Mey J and McCaffery P. Retinoic acid signaling in the nervous system of adult vertebrates. Neuroscientist 2004; 10: 409-421.
5. Wong LF, Yip PK, Battaglia A, Grist J, Corcoran J, Maden M, Azzouz M, Kingsman SM, Kingsman AJ, Mazarakis ND and McMahon SB. Retinoic acid receptor beta2 promotes functional regeneration of sensory axons in the spinal cord. Nat Neurosci 2006; 9: 243-250.
6. Harvey BK, Shen H, Chen GJ, Yoshida Y and Wang Y. Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats. Neurosci Lett 2004; 369: 138-141.
7. Corcoran J, So PL, Barber RD, Vincent KJ, Mazarakis ND, Mitrophanous KA, Kingsman SM and Maden M. Retinoic acid receptor beta2 and neurite outgrowth in the adult mouse spinal cord in vitro. J Cell Sci 2002; 115: 3779- 3786.
8. Corcoran JP, So PL and Maden M. Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci 2004; 20: 896-902.
9. Craft NE, Haitema TB, Garnett KM, Fitch KA and Dorey CK. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging 2004; 8: 156-162.
10. Ahlemeyer B, Bauerbach E, Plath M, Steuber M, Heers C, Tegtmeier F and Krieglstein J. Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level. Free Radic Biol Med 2001; 30: 1067-1077.
11. Yoo HY, Chang MS and Rho HM. Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 1999; 234: 87-91.
12. Malaspina A, Kaushik N and de Belleroche J. A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord. J Neurochem 2000; 75: 2511-2520.
13. Malaspina A, Kaushik N and de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 2001; 77: 132-145.
14. Malaspina A and de Belleroche J. Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis. Brain Res Brain Res Rev 2004; 45: 213-229.
15. Jiang YM, Yamamoto M, Kobayashi Y, Yoshihara T, Liang Y, Terao S, Takeuchi H, Ishigaki S, Katsuno M, Adachi H, Niwa J, Tanaka F, Doyu M, Yoshida M, Hashizume Y and Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 2005; 57: 236-251.
16. Dangond F, Hwang D, Camelo S, Pasinelli P, Frosch MP, Stephanopoulos G, Stephanopoulos G, Brown RH, Jr. and Gullans SR. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics 2004; 16: 229- 239.
17. Yoshihara T, Ishigaki S, Yamamoto M, Liang Y, Niwa J, Takeuchi H, Doyu M and Sobue G. Differential expression of inflammation- and apoptosis- related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 2002; 80: 158-167.
18. Jokic N, Ling YY, Ward RE, Michael-Titus AT, Priestley JV and Malaspina A. Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis. J Neurochem 2007; 103: 1821-1833.
19. Corcoran J, So PL and Maden M. Absence of retinoids can induce motoneuron disease in the adult rat and a retinoid defect is present in motoneuron disease patients. J Cell Sci 2002; 115: 4735-4741.
20. Malaspina A and Turkheimer F. A review of the functional role and of the expression profile of retinoid signaling and of nuclear receptors in human spinal cord. Brain Res Bull 2007; 71: 437-446.
21. Siegenthaler G. Extra-and intracellular transport of retinoids: a reappraisal. Horm Res 1996; 45: 122-127.
22. Napoli JL. Biosynthesis and metabolism of retinoic acid: roles of CRBP and CRABP in retinoic acid: roles of CRBP and CRABP in retinoic acid homeostasis. J Nutr 1993; 123: 362-366.
23. Ghyselinck NB, Bavik C, Sapin V, Mark M, Bonnier D, Hindelang C, Dierich A, Nilsson CB, Hakansson H, Sauvant P, Azais-Braesco V, Frasson M, Picaud S and Chambon P. Cellular retinol-binding protein I is essential for vitamin A homeostasis. Embo J 1999; 18: 4903-4914.
24. Boylan JF and Gudas LJ. The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J Biol Chem 1992; 267: 21486-21491.
25. Delva L, Bastie JN, Rochette-Egly C, Kraiba R, Balitrand N, Despouy G, Chambon P and Chomienne C. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 1999; 19: 7158- 7167.
26. Leid M, Kastner P and Chambon P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 1992; 17: 427-433.
27. Jonk LJ, de Jonge ME, Vervaart JM, Wissink S and Kruijer W. Isolation and developmental expression of retinoic-acid-induced genes. Dev Biol 1994; 161: 604-614.
28. Mangelsdorf DJ and Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83: 841-850.
29. Kastner P, Chambon, P., and Leid, M. Role of nuclear retinoic acid receptors in the regulation of gene expression. In: Blomhoff R, editors. Vitamin A in Health and Disease. New York: Marcel Dekker Inc.; 1994. p. 189-238.
30. Kliewer SA, Umesono, K., Evans, R.M. and Mangelsdorf, D.J. The retinoid X receptors: modulators of multiple hormonal signalling pathways. In: Blomhoff R, editors. Vitamin A in Health and Disease. New York: Marcel Dekker Inc.; 1994. p. 239-255.
31. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita V-M, Kaivorinee AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M, Consortium TI, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaey Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ and Traynor BJ. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257-268.
32. Ranganathan S and Bowser R. Alterations in G (1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol 2003; 162: 823-835.
33. Jordan-Sciutto KL, Dragich JM and Bowser R. DNA binding activity of the fetal Alz-50 clone 1 (FAC1) protein is enhanced by phosphorylation. Biochem Biophys Res Commun 1999; 260: 785-789.
34. Hanson MG, Jr., Shen S, Wiemelt AP, McMorris FA and Barres BA. Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J Neurosci 1998; 18: 7361- 7371.
35. Ullian EM, Harris BT, Wu A, Chan JR and Barres BA. Schwann cells and astrocytes induce synapse formation by spinal motor neurons in culture. Mol Cell Neurosci 2004; 25: 241-251.
36. Stommel EW, van Hoff RM, Graber DJ, Bercury KK, Langford GM and Harris BT. Tumor necrosis factor-alpha induces changes in mitochondrial cellular distribution in motor neurons. Neuroscience 2007; 146: 1013-1019.
37. Deasy BM, Lu A, Tebbets JC, Feduska JM, Schugar RC, Pollett JB, Sun B, Urish KL, Gharaibeh BM, Cao B, Rubin RT and Huard J. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol 2007; 177: 73-86.
38. Kada N, Suzuki T, Aizawa K, Matsumura T, Ishibashi N, Suzuki N, Takeda N, Munemasa Y, Sawaki D, Ishikawa T and Nagai R. Acyclic retinoid inhibits neointima formation through retinoic acid receptor beta-induced apoptosis. Arterioscler Thromb Vasc Biol 2007; 27: 1535- 1541.
39. Chang Q, Chen Z, You J, McNutt MA, Zhang T, Han Z, Zhang X, Gong E and Gu J. All-transretinoic acid induces cell growth arrest in a human medulloblastoma cell line. J Neurooncol 2007; 84: 263-267.
40. Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R and Koeffler HP. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. Int J Oncol 2004; 25: 493-502.
41. Mey J. New therapeutic target for CNS injury? The role of retinoic acid signaling after nerve lesions. J Neurobiol 2006; 66: 757-779.
42. Camu W and Henderson CE. Purification of embryonic rat motoneurons by panning on a monoclonal antibody to the low-affinity NGF receptor. J Neurosci Methods 1992; 44: 59-70.
43. Camu W and Henderson CE. Rapid purification of embryonic rat motoneurons: an in vitro model for studying MND/ALS pathogenesis. J Neurol Sci 1994; 124 Suppl: 73-74.
44. Barber SC and Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 2010; 48: 629- 641.
45. Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown RH, Jr. and Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem 2005; 95: 1461- 1471.
46. Ryberg H, An J, Darko S, Lustgarten JL, Jaffa M, Gopalakrishnan V, Lacomis D, Cudkowicz M and Bowser R. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve 2010; 42: 104-111.
47. Mailhos C, Howard, M. K., Latchman, D. S.,. A common pathway mediates retinoic acid and PMA-dependent programmed cell death (apoptosis) of neuronal cells. Brain Res 1994; 664: 7-12.
48. Okazawa H, Shimizu, J., Kamei, M., Imafuku, I., Hamada, H., Kanazawa, I. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J. Cell Biol. 1996; 132: 955-968.
49. Tong L, Werrbach-Perez, K., Perez-Polo, J. R. Retinoic acid induces apoptosis in PC12 cells independent of neurotrophic factors. J. Neurochem. 1997; 68: 1424-1434.
50. Ahlemeyer B and Krieglstein J. Retinoic acid reduces staurosporine-induced apoptotic damage in chick embryonic neurons by suppressing reactive oxygen species production. Neurosci Lett 1998; 246: 93-96.
51. Moreno-Manzano V, Ishikawa Y, Lucio-Cazana J and Kitamura M. Suppression of apoptosis by all-trans-retinoic acid. Dual intervention in the c -Jun n-terminal kinase-AP-1 pathway. J Biol Chem 1999; 274: 20251-20258.
52. Ahlemeyer B and Krieglstein J. Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine- induced oxidative stress and apoptosis. Neurochem Int 2000; 36: 1-5.
53. Corcoran J and Maden M. Nerve growth factor acts via retinoic acid synthesis to stimulate neurite outgrowth. Nat Neurosci 1999; 2: 307- 308.
54. Corcoran J, Shroot B, Pizzey J and Maden M. The role of retinoic acid receptors in neurite outgrowth from different populations of embryonic mouse dorsal root ganglia. J Cell Sci 2000; 113 (Pt 14): 2567-2574.
55. Fukunaka K, Saito T, Wataba K, Ashihara K, Ito E and Kudo R. Changes in expression and subcellular localization of nuclear retinoic acid receptors in human endometrial epithelium during the menstrual cycle. Mol Hum Reprod 2001; 7: 437-446.
56. Braun KW, Tribley WA, Griswold MD and Kim KH. Follicle-stimulating hormone inhibits alltrans- retinoic acid-induced retinoic acid receptor alpha nuclear localization and transcriptional activation in mouse Sertoli cell lines. J Biol Chem 2000; 275: 4145-4151.
57. Maruvada P, Baumann CT, Hager GL and Yen PM. Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J Biol Chem 2003; 278: 12425-12432.
58. Pavan B, Dalpiaz A, Biondi C, Nieddu M, De Luca A, Prasad PD, Paganetto G and Favaloro B. An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. Biosci Rep 2008; 28: 327-334.
59. Balmer JE and Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 2002; 43: 1773-1808.
60. Calingasan NY, Chen J, Kiaei M and Beal MF. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol Dis 2005; 19: 340-347.
61. Koistinen H, Prinjha R, Soden P, Harper A, Banner SJ, Pradat PF, Loeffler JP and Dingwall C. Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease. Muscle Nerve 2006; 34: 444-450.
62. Hamilton RL and Bowser R. Alzheimer disease pathology in amyotrophic lateral sclerosis. Acta Neuropathol 2004; 107: 515-522.
63. Beuche W, Yushchenko M, Mader M, Maliszewska M, Felgenhauer K and Weber F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport 2000; 11: 3419-3422.
64. Demestre M, Parkin-Smith G, Petzold A and Pullen AH. The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J Neuroimmunol 2005; 159: 146-154.
65. Lorenzl S, Albers DS, LeWitt PA, Chirichigno JW, Hilgenberg SL, Cudkowicz ME and Beal MF. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J Neurol Sci 2003; 207: 71-76.
66. He BP, Wen W and Strong MJ. Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. J Neuroimmunol 2002; 128: 31-38.
67. Schrage K, Koopmans G, Joosten EA and Mey J. Macrophages and neurons are targets of retinoic acid signaling after spinal cord contusion injury. Eur J Neurosci 2006; 23: 285-295.
68. Czernielewski J, Michel S, Bouclier M, Baker M and Hensby JC. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol 2001; 15 Suppl 3: 5-12.
69. DiSilvestro PA, DiSilvestro JM, Lernhardt W, Pfahl M and Mannel RS. Treatment of cervical intraepithelial neoplasia levels 2 and 3 with adapalene, a retinoid-related molecule. J Low Genit Tract Dis 2001; 5: 33-37.